{"id":369560,"date":"2025-12-11T14:00:01","date_gmt":"2025-12-11T08:30:01","guid":{"rendered":"https:\/\/www.scconline.com\/blog\/?p=369560"},"modified":"2025-12-11T13:38:43","modified_gmt":"2025-12-11T08:08:43","slug":"shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025","status":"publish","type":"post","link":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/11\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\/","title":{"rendered":"Shardul Amarchand Mangaldas &#038; Co. advises Biocon Limited on its Acquisition of Shares in Biocon Biologics Limited for USD 1.2 billion"},"content":{"rendered":"<div style=\"text-align: justify; line-height: 150%;\">\n<p style=\"margin-bottom: 3%;\"><span style=\"font-weight: bold;\">New Delhi | December 10th, 2025:<\/span> Shardul Amarchand Mangaldas &amp; Co. (SAM) advised Biocon Limited (&#8220;BL&#8221;) and its subsidiary Biocon Biologics Limited (&#8220;BBL&#8221;) on their ~USD 1.2 billion integration, involving BL&#8217;s acquisition of minority shareholdings in BBL from Viatris, Serum Institute Lifesciences, Tata Capital Growth Fund II and True North.<\/p>\n<p style=\"margin-bottom: 3%;\">The Transaction Team was led by Raghubir Menon, Partner and Regional Practice Head &#8212; Mumbai, M&amp;A and Private Equity, General Corporate; and Natashaa Shroff, Partner, along with Tarumoy Chaudhuri, Partner; Rounak Agarwal, Principal Associate; Kriti Saraswat, Senior Associate; Sohini Banerjee, Associate; Mihira Jaggi, Associate; and Anushya Ramakrishna, Associate.<\/p>\n<p style=\"margin-bottom: 3%;\">The Competition Team was led by Shweta Shroff Chopra, Partner, and Supritha Prodaturi, Partner, supported by Parinita Kare, Senior Associate; Vasudha Verma, Associate; Saii S., Associate; and Janhavi Jyoti S., Associate.<\/p>\n<p style=\"margin-bottom: 3%;\">The Capital Markets Team included Prashant Gupta, Partner &#8212; National Practice Head &#8212; Capital Markets; Ruth Chenchiah, Partner; and Debolina Mitra, Senior Associate.<\/p>\n<p style=\"margin-bottom: 3%;\">The Banking &amp; Finance Team comprised Shubhangi Garg, Partner, and Ansh Jain, Associate.<\/p>\n<p style=\"margin-bottom: 3%;\">The Securities Team included Yogesh Chande, Partner, and Anushri Mandal, Associate.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p style=\"font-style: italic;\">Shardul Amarchand Mangaldas advised Biocon Limited on its ~USD 1.2 billion integration involving acquisition of minority stakes in Biocon Biologics from multiple investors.<\/p>\n","protected":false},"author":67011,"featured_media":369567,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[45282,2],"tags":[94686,94680,94681,94685,94683,46701,94684,85282,94682],"class_list":["post-369560","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-law-firms-news","category-news","tag-billion-dollar-pharma-deal","tag-biocon-acquisition","tag-biocon-biologics-integration","tag-ma-pharma-india","tag-serum-institute-lifesciences","tag-shardul-amarchand-mangaldas","tag-tata-capital-growth-fund-ii","tag-true-north","tag-viatris-stake-sale"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.4 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Shardul Amarchand Advises Biocon on USD 1.2 Billion Biologics Integration | SCC Times<\/title>\n<meta name=\"description\" content=\"SAM advised Biocon on its USD 1.2 billion integration involving acquisition of minority stakes in Biocon Biologics.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/11\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Shardul Amarchand Mangaldas &amp; Co. advises Biocon Limited on its Acquisition of Shares in Biocon Biologics Limited for USD 1.2 billion\" \/>\n<meta property=\"og:description\" content=\"SAM advised Biocon on its USD 1.2 billion integration involving acquisition of minority stakes in Biocon Biologics.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/11\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"SCC Times\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/scc.online\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-11T08:30:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Biocon-Biologics-integration.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"886\" \/>\n\t<meta property=\"og:image:height\" content=\"590\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Editor\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Shardul Amarchand Mangaldas &amp; Co. advises Biocon Limited on its Acquisition of Shares in Biocon Biologics Limited for USD 1.2 billion\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Editor\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/12\\\/11\\\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/12\\\/11\\\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\\\/\"},\"author\":{\"name\":\"Editor\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/#\\\/schema\\\/person\\\/84e42bab48238baf12c7e33b3d9761fe\"},\"headline\":\"Shardul Amarchand Mangaldas &#038; Co. advises Biocon Limited on its Acquisition of Shares in Biocon Biologics Limited for USD 1.2 billion\",\"datePublished\":\"2025-12-11T08:30:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/12\\\/11\\\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\\\/\"},\"wordCount\":192,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/12\\\/11\\\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Biocon-Biologics-integration.webp\",\"keywords\":[\"billion dollar pharma deal\",\"Biocon acquisition\",\"Biocon Biologics integration\",\"M&amp;A pharma India\",\"Serum Institute Lifesciences\",\"Shardul Amarchand Mangaldas\",\"Tata Capital Growth Fund II\",\"True North\",\"Viatris stake sale\"],\"articleSection\":[\"Law Firms News\",\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/12\\\/11\\\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/12\\\/11\\\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\\\/\",\"url\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/12\\\/11\\\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\\\/\",\"name\":\"Shardul Amarchand Advises Biocon on USD 1.2 Billion Biologics Integration | SCC Times\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/12\\\/11\\\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/12\\\/11\\\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Biocon-Biologics-integration.webp\",\"datePublished\":\"2025-12-11T08:30:01+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/#\\\/schema\\\/person\\\/84e42bab48238baf12c7e33b3d9761fe\"},\"description\":\"SAM advised Biocon on its USD 1.2 billion integration involving acquisition of minority stakes in Biocon Biologics.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/12\\\/11\\\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/12\\\/11\\\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/12\\\/11\\\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Biocon-Biologics-integration.webp\",\"contentUrl\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Biocon-Biologics-integration.webp\",\"width\":886,\"height\":590,\"caption\":\"Biocon Biologics integration\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/12\\\/11\\\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shardul Amarchand Mangaldas &#038; Co. advises Biocon Limited on its Acquisition of Shares in Biocon Biologics Limited for USD 1.2 billion\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/\",\"name\":\"SCC Times\",\"description\":\"Bringing you the Best Analytical Legal News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/#\\\/schema\\\/person\\\/84e42bab48238baf12c7e33b3d9761fe\",\"name\":\"Editor\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g\",\"caption\":\"Editor\"},\"url\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/author\\\/editor_4\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Shardul Amarchand Advises Biocon on USD 1.2 Billion Biologics Integration | SCC Times","description":"SAM advised Biocon on its USD 1.2 billion integration involving acquisition of minority stakes in Biocon Biologics.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/11\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\/","og_locale":"en_US","og_type":"article","og_title":"Shardul Amarchand Mangaldas & Co. advises Biocon Limited on its Acquisition of Shares in Biocon Biologics Limited for USD 1.2 billion","og_description":"SAM advised Biocon on its USD 1.2 billion integration involving acquisition of minority stakes in Biocon Biologics.","og_url":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/11\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\/","og_site_name":"SCC Times","article_publisher":"https:\/\/www.facebook.com\/scc.online\/","article_published_time":"2025-12-11T08:30:01+00:00","og_image":[{"width":886,"height":590,"url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Biocon-Biologics-integration.jpg","type":"image\/jpeg"}],"author":"Editor","twitter_card":"summary_large_image","twitter_title":"Shardul Amarchand Mangaldas & Co. advises Biocon Limited on its Acquisition of Shares in Biocon Biologics Limited for USD 1.2 billion","twitter_misc":{"Written by":"Editor","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/11\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\/#article","isPartOf":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/11\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\/"},"author":{"name":"Editor","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe"},"headline":"Shardul Amarchand Mangaldas &#038; Co. advises Biocon Limited on its Acquisition of Shares in Biocon Biologics Limited for USD 1.2 billion","datePublished":"2025-12-11T08:30:01+00:00","mainEntityOfPage":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/11\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\/"},"wordCount":192,"commentCount":0,"image":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/11\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Biocon-Biologics-integration.webp","keywords":["billion dollar pharma deal","Biocon acquisition","Biocon Biologics integration","M&amp;A pharma India","Serum Institute Lifesciences","Shardul Amarchand Mangaldas","Tata Capital Growth Fund II","True North","Viatris stake sale"],"articleSection":["Law Firms News","News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.scconline.com\/blog\/post\/2025\/12\/11\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/11\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\/","url":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/11\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\/","name":"Shardul Amarchand Advises Biocon on USD 1.2 Billion Biologics Integration | SCC Times","isPartOf":{"@id":"https:\/\/www.scconline.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/11\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/11\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Biocon-Biologics-integration.webp","datePublished":"2025-12-11T08:30:01+00:00","author":{"@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe"},"description":"SAM advised Biocon on its USD 1.2 billion integration involving acquisition of minority stakes in Biocon Biologics.","breadcrumb":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/11\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.scconline.com\/blog\/post\/2025\/12\/11\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/11\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\/#primaryimage","url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Biocon-Biologics-integration.webp","contentUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Biocon-Biologics-integration.webp","width":886,"height":590,"caption":"Biocon Biologics integration"},{"@type":"BreadcrumbList","@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/11\/shardul-amarchand-biocon-biologics-usd-1-2-billion-integration-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.scconline.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Shardul Amarchand Mangaldas &#038; Co. advises Biocon Limited on its Acquisition of Shares in Biocon Biologics Limited for USD 1.2 billion"}]},{"@type":"WebSite","@id":"https:\/\/www.scconline.com\/blog\/#website","url":"https:\/\/www.scconline.com\/blog\/","name":"SCC Times","description":"Bringing you the Best Analytical Legal News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.scconline.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe","name":"Editor","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g","caption":"Editor"},"url":"https:\/\/www.scconline.com\/blog\/post\/author\/editor_4\/"}]}},"jetpack_featured_media_url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Biocon-Biologics-integration.webp","jetpack_sharing_enabled":true,"jetpack-related-posts":[],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/369560","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/users\/67011"}],"replies":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/comments?post=369560"}],"version-history":[{"count":0,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/369560\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media\/369567"}],"wp:attachment":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media?parent=369560"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/categories?post=369560"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/tags?post=369560"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}